Labeler
Upsher-Smith Laboratories, LLC NDC Codes
Upsher-Smith Laboratories, LLC lists 221 finished drug products in the FDA NDC Directory under NDC labeler codes 0245, 0832, 24979, 80789.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Fluphenazine Hydrochloride, Zestril, Kymbee, Deflazacort, Tadalafil, Dicyclomine Hydrochloride, Torpenz, Isotretinoin, Naprelan, Tenormin, Naproxen Sodium, Galantamine, Pitavastatin, Diltiazem Hydrochloride, Fluvoxamine Maleate
- Active ingredients
- Deflazacort, Fluphenazine hydrochloride, Naproxen sodium, Potassium chloride, Lisinopril, Tadalafil, Dicyclomine hydrochloride, Everolimus, Isotretinoin, Brimonidine tartrate, Atenolol, Galantamine hydrobromide
- NDC labeler codes
- 0245, 0832, 24979, 80789
- Strengths (from the 100 most recently listed products)
- Potassium chloride 750 mg/1; Naproxen sodium 375 mg/1; Naproxen sodium 500 mg/1; Naproxen sodium 750 mg/1; Potassium chloride 600 mg/1; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Bupropion hydrochloride 450 mg/1; Dicyclomine hydrochloride 20 mg/1; Dicyclomine hydrochloride 10 mg/1; Fluphenazine hydrochloride 1 mg/1; Fluphenazine hydrochloride 5 mg/1; Fluphenazine hydrochloride 10 mg/1; Fluphenazine hydrochloride 2.5 mg/1; Deflazacort 22.75 mg/mL; Fluvoxamine maleate 150 mg/1; Fluvoxamine maleate 100 mg/1; Cyclosporine .5 mg/mL
- Dosage forms
- Tablet, Tablet, Film coated, Tablet, Film coated, Extended release, Tablet, Extended release, Capsule, Extended release, Capsule, Capsule, Delayed release, Capsule, Liquid filled, Solution/ drops, Suspension, Emulsion, Injection, Solution, Solution, Tablet, Delayed release, Powder, For suspension, For solution
- Routes
- Oral, Ophthalmic, Subcutaneous, Auricular (Otic)
- Drug classes (FDA established)
- Corticosteroid, Phenothiazine, Kinase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Osmotic Laxative, Potassium Salt, Angiotensin Converting Enzyme Inhibitor, beta-Adrenergic Blocker, Phosphodiesterase 5 Inhibitor, Anticholinergic, mTOR Inhibitor Immunosuppressant, Retinoid, Serotonin Reuptake Inhibitor, alpha-Adrenergic Agonist, Cholinesterase Inhibitor, HMG-CoA Reductase Inhibitor, Calcium Channel Blocker, Mood Stabilizer, Fluoroquinolone Antibacterial, Aromatase Inhibitor, Anti-epileptic Agent, Aminoketone, Proton Pump Inhibitor, Antimetabolite Immunosuppressant, Calcineurin Inhibitor Immunosuppressant, Histamine-2 Receptor Antagonist, Aminosalicylate, Melatonin Receptor Agonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 138 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Jantovenwarfarin sodium | Warfarin sodium 7.5 mg/1 | TabletOral | 0832-1218 | 00832-1218-0000832-1218-0100832-1218-50 | — |
| Jantovenwarfarin sodium | Warfarin sodium 10 mg/1 | TabletOral | 0832-1219 | 00832-1219-0000832-1219-0100832-1219-50 | — |
| Jantovenwarfarin sodium | Warfarin sodium 6 mg/1 | TabletOral | 0832-1217 | 00832-1217-0000832-1217-0100832-1217-10 | — |
| Jantovenwarfarin sodium | Warfarin sodium 1 mg/1 | TabletOral | 0832-1211 | 00832-1211-0000832-1211-0100832-1211-10 | — |
| Jantovenwarfarin sodium | Warfarin sodium 2 mg/1 | TabletOral | 0832-1212 | 00832-1212-0000832-1212-0100832-1212-10 | — |
| Bethanechol Chloride | Bethanechol chloride 5 mg/1 | TabletOral | 0832-0510 | 00832-0510-0000832-0510-0100832-0510-10 | — |
| Bethanechol Chloride | Bethanechol chloride 10 mg/1 | TabletOral | 0832-0511 | 00832-0511-0000832-0511-0100832-0511-10+1 more | — |
| Bethanechol Chloride | Bethanechol chloride 25 mg/1 | TabletOral | 0832-0512 | 00832-0512-0000832-0512-0100832-0512-10+2 more | — |
| Bethanechol Chloride | Bethanechol chloride 50 mg/1 | TabletOral | 0832-0513 | 00832-0513-0000832-0513-0100832-0513-10+1 more | — |
| Potassium Citrate | Potassium citrate 5 meq/1 | TabletOral | 0245-0070 | 00245-0070-11 | — |
| Potassium Citrate | Potassium citrate 10 meq/1 | TabletOral | 0245-0071 | 00245-0071-11 | — |
| Vandazolemetronidazole | Metronidazole 7.5 mg/g | GelVaginal | 0245-0860 | 00245-0860-70 | — |
| Nyamycnystatin | Nystatin 100000 [USP'U]/g | PowderTopical | 0832-0465 | 00832-0465-1500832-0465-3000832-0465-60 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 5 mg/1 | TabletOral | 0245-0212 | 00245-0212-0100245-0212-11 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 2.5 mg/1 | TabletOral | 0245-0211 | 00245-0211-0100245-0211-11 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 10 mg/1 | TabletOral | 0245-0213 | 00245-0213-0100245-0213-11 | — |
| Prevalitecholestyramine | Cholestyramine 4 g/5.5g | Powder, For suspensionOral | 0245-0036 | 00245-0036-2300245-0036-4200245-0036-60 | — |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Film coated, Extended releaseOral | 0832-5323 | 00832-5323-1000832-5323-11 | — |
| Klor-Conpotassium chloride | Potassium chloride 600 mg/1 | Tablet, Film coated, Extended releaseOral | 0245-5315 | 00245-5315-0100245-5315-1100245-5315-15 | — |
| Klor-Conpotassium chloride | Potassium chloride 750 mg/1 | Tablet, Film coated, Extended releaseOral | 0245-5316 | 00245-5316-0100245-5316-1100245-5316-15 | — |
| Potassium Chloride | Potassium chloride 600 mg/1 | Tablet, Film coated, Extended releaseOral | 0832-5322 | 00832-5322-1000832-5322-11 | — |
Upsher-Smith Laboratories, LLC: common questions
- What is Upsher-Smith Laboratories, LLC's NDC labeler code?
- 0245, 0832, 24979, 80789. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Upsher-Smith Laboratories, LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.